| Primary |
| Pulmonary Arterial Hypertension |
92.6% |
| Cor Pulmonale Chronic |
3.7% |
| Portopulmonary Hypertension |
1.9% |
| Pulmonary Hypertension |
0.9% |
| Product Used For Unknown Indication |
0.7% |
| Digital Ulcer |
0.1% |
| Maternal Exposure During Pregnancy |
0.1% |
|
| Death |
16.1% |
| Pneumonia |
12.3% |
| Vomiting |
11.0% |
| Pulmonary Arterial Hypertension |
7.7% |
| Weight Decreased |
7.1% |
| Right Ventricular Failure |
6.8% |
| Weight Increased |
3.9% |
| Urinary Tract Infection |
3.5% |
| Medical Device Complication |
3.2% |
| Dyspnoea |
2.9% |
| Lung Transplant |
2.9% |
| Malaise |
2.9% |
| Pyrexia |
2.9% |
| Renal Failure |
2.9% |
| Sepsis |
2.9% |
| Syncope |
2.9% |
| Nausea |
2.3% |
| Infection |
1.9% |
| Rash |
1.9% |
| Thrombosis In Device |
1.9% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
92.2% |
| Product Used For Unknown Indication |
3.9% |
| Pulmonary Hypertension |
1.8% |
| Portopulmonary Hypertension |
1.2% |
| Connective Tissue Disorder |
0.6% |
| Cor Pulmonale Chronic |
0.3% |
|
| Vomiting |
16.7% |
| Weight Decreased |
12.1% |
| Pulmonary Arterial Hypertension |
10.6% |
| Weight Increased |
6.1% |
| Pneumonia |
5.3% |
| Pulmonary Oedema |
5.3% |
| Right Ventricular Failure |
5.3% |
| Syncope |
5.3% |
| Tremor |
5.3% |
| Thrombocytopenia |
4.5% |
| Vision Blurred |
4.5% |
| Nausea |
3.0% |
| Respiratory Failure |
3.0% |
| Wound Infection |
3.0% |
| Renal Failure |
2.3% |
| Device Related Infection |
1.5% |
| Dyspnoea |
1.5% |
| Headache |
1.5% |
| Pain In Jaw |
1.5% |
| Paraesthesia |
1.5% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
29.8% |
| Product Used For Unknown Indication |
26.6% |
| Pulmonary Hypertension |
24.5% |
| Cor Pulmonale Chronic |
2.1% |
| Anaemia |
1.1% |
| Anxiety |
1.1% |
| Atrial Septal Defect |
1.1% |
| Carcinoid Tumour |
1.1% |
| Cardiac Failure Congestive |
1.1% |
| Chronic Respiratory Failure |
1.1% |
| Coronary Artery Disease |
1.1% |
| Headache |
1.1% |
| Hypothyroidism |
1.1% |
| Klippel-trenaunay Syndrome |
1.1% |
| Nausea |
1.1% |
| Portal Hypertension |
1.1% |
| Portopulmonary Hypertension |
1.1% |
| Scleroderma |
1.1% |
| Systemic Sclerosis |
1.1% |
| Ventricular Dysfunction |
1.1% |
|
| Death |
21.9% |
| Right Ventricular Failure |
9.4% |
| Dyspnoea |
6.3% |
| Malaise |
6.3% |
| Pulmonary Hypertension |
6.3% |
| Syncope |
6.3% |
| Cardiac Failure Acute |
3.1% |
| Catheter Management |
3.1% |
| Catheter Placement |
3.1% |
| Catheter Site Haemorrhage |
3.1% |
| Catheter Site Pain |
3.1% |
| Chest Pain |
3.1% |
| Complications Of Transplanted Liver |
3.1% |
| Device Leakage |
3.1% |
| Device Related Infection |
3.1% |
| Disease Progression |
3.1% |
| Fluid Overload |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Heart Rate Increased |
3.1% |
| Hypoxia |
3.1% |
|
